The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of itraconazole or rifampicin on the pharmacokinetics (PK) of osimertinib (AZD9291).
 
Karthick Vishwanathan
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
Research Funding - AstraZeneca (Inst)
Patents, Royalties, Other Intellectual Property - AstraZeneca (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
James Chih-Hsin Yang
Honoraria - AstraZeneca; Boehringer Ingelheim; Chugai Pharma; MSD; Roche
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; AstraZeneca (Inst); Bayer; Boehringer Ingelheim; Boehringer Ingelheim (Inst); Bristol-Myers Squibb; Celgene; Clovis Oncology; Lilly; Merck Serono; MSD Oncology; Novartis; Ono Pharmaceutical; Pfizer; Roche/Genentech
 
Jong-Seok Lee
No Relationships to Disclose
 
Matthew Krebs
No Relationships to Disclose
 
Paul A. Dickinson
Employment - AstraZeneca
Leadership - Seda Pharmaceutical Development Services
Stock and Other Ownership Interests - AstraZeneca
Other Relationship - Seda Pharmaceutical Development Services
 
Khanh Bui
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
Consulting or Advisory Role - AstraZeneca
 
Doris Weilert
Employment - Quintiles
 
Karen So
Employment - AstraZeneca
 
Karen Thomas
Employment - AstraZeneca
 
R Donald Harvey
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Takeda
Research Funding - Abbott Biotherapeutics (Inst); Acetylon Pharmaceuticals (Inst); Agensys (Inst); Amgen (Inst); ArQule (Inst); AstraZeneca (Inst); AVEO (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Celgene (Inst); Cleave Biosciences (Inst); Eisai (Inst); Genzyme (Inst); ImClone Systems (Inst); Merck (Inst); Millennium (Inst); Novartis (Inst); Onyx (Inst); Pfizer (Inst); Sanofi (Inst); Synta (Inst)